Showing results (381-390 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|January 1, 1987
Selection frequency of resistant variants by various beta-lactam antibiotics in clinical Enterobacter cloacae isolatesK H Büscher, W Cullmann, W Dick, et al.Chemotherapy|January 1, 1986
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureusJ Unowsky, P H Chandrasekar, W DeLorenzo, et al.Chemotherapy|January 1, 1988
Elimination of antibiotic-resistant plasmids by quinolone antibioticsK P Fu, M E Grace, C L Hsiao, et al.Chemotherapy|May 14, 2014
Antibiotic resistance of gram-negative bacilli isolated from pediatric patients with nosocomial bloodstream infections in a Mexican tertiary care hospitalMiguel Ángel Ares, Maria Dolores Alcántar-Curiel, César Jiménez-Galicia, et al.Chemotherapy|March 7, 2021
Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real LifePierantonio Menna, Emanuela Salvatorelli, Maria Ilaria Del Principe, et al.Chemotherapy|April 19, 2017
Retrospective Analysis of the Risk Factors for Grade IV Neutropenia in Oesophageal Cancer Patients Treated with a Docetaxel, Cisplatin, and 5-Fluorouracil RegimenMasahito Naito, Tomoya Yamamoto, Chikao Shimamoto, et al.Chemotherapy|January 1, 1988
In vitro activity of three fluoroquinolones against enterococci and Pseudomonas aeruginosa: modified categorization system for discrepant broth dilution and agar disk diffusion test resultsW H Traub, K H Kohl, M SpohrChemotherapy|June 29, 2012
Gallic acid as a cancer-selective agent induces apoptosis in pancreatic cancer cellsZuojia Liu, Dan Li, Lijun Yu, et al.Chemotherapy|July 21, 2012
Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysisSissy Muro, Elvira Garza-González, Adrian Camacho-Ortiz, et al.Pageof 308